Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 4,814 | 3,600 | 28,938 | 57,052 | 0 |
| Gross Profit | 4,814 | 3,600 | 28,938 | 57,052 | N/A |
| Operating Expenses | 21,475 | 20,576 | 17,930 | 14,830 | 13,362 |
| Operating Income | -16,661 | -16,976 | 11,008 | 42,222 | -13,362 |
| Other Income | 127 | -25 | 21 | -53 | 107 |
| Pre-tax Income | -16,534 | -17,001 | 11,029 | 42,169 | -13,255 |
| Net Income Continuous | -16,534 | -17,001 | 11,029 | 42,169 | -13,255 |
| Net Income | $-16,534 | $-17,001 | $11,029 | $42,169 | $-13,255 |
| EPS Basic Total Ops | -0.47 | -1.39 | N/A | 26.03 | -8.53 |
| EPS Basic Continuous Ops | -0.47 | -1.39 | 5.81 | 27.24 | -7.73 |
| EPS Diluted Total Ops | -0.47 | -1.39 | N/A | 26.03 | -8.53 |
| EPS Diluted Continuous Ops | -0.47 | -1.39 | 5.81 | 27.24 | -7.73 |
| EBITDA(a) | $-16,331 | $-16,655 | $11,320 | $42,512 | $-13,075 |